Adora Ndu is a director of Acadia Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Feb 24 | DBVT DBV Technologies | Ordinary Shares | Buy | Acquire P | No | No | 0.89 | 1,825 | 1.62 k | 1,825 |
12 Oct 23 | ACAD Acadia Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,381 | 0.00 | 4,381 |
12 Oct 23 | ACAD Acadia Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,381 | 0.00 | 4,381 |
1 Jun 23 | ACAD Acadia Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 6,652 | 0.00 | 6,652 |
1 Jun 23 | ACAD Acadia Pharmaceuticals | Director Stock Options Common Stock | Grant | Acquire A | No | No | 23.9 | 11,045 | 263.98 k | 11,045 |
12 Oct 22 | ACAD Acadia Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 8,762 | 0.00 | 8,762 |
12 Oct 22 | ACAD Acadia Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 17.12 | 14,077 | 241.00 k | 14,077 |